Source

df

Mean squares

CMD 3 MAP

CMD 6 MAP

CMD 9 MAP

CBSD 3 MAP

CBSD 6 MAP

CBSD 9 MAP

Treatment

479

0.19***

0.36***

0.26***

0.88***

1.26***

1.02***

Genotype (G)

15

1.37***

2.92***

2.23***

17.15***

25.70***

22.43***

Environment (E)

29

1.28***

2.54***

1.80***

0.61***

1.30***

0.79***

Block

60

0.08***

0.10*

0.08***

0.11

0.16*

0.09

Interaction (G^*E)

435

0.08***

0.13***

0.09***

0.34***

0.42***

0.29***

IPCA1

43

0.33***

0.58***

0.38***

1.43***

1.73***

1.09***

IPCA2

41

0.20***

0.48***

0.27***

0.83***

1.36***

0.84***

IPCA3

39

0.13***

0.11*

0.11***

0.39***

0.47*

0.27***

IPCA4

37

0.05*

0.06

0.05

0.35*

0.34

0.28*

IPCA5

35

0.03

0.04

0.04

0.22

0.25

0.24

Error

899

0.03

0.07

0.04

0.13

0.11

0.09

Sum of squares

Treatment

479

90.70

172.62

122.59

422.50

603.30

486.50

Genotype (G)

15

20.51

43.87

33.40

257.32

385.55

336.38

Environment (E)

29

37.22

73.55

52.18

17.68

37.72

22.94

Block

60

4.47

6.16

4.99

6.31

9.83

5.34

Interaction (G^*E)

435

32.97

55.20

37.01

147.50

180.03

127.18

IPCA1

43

14.08

24.95

16.16

61.59

74.45

46.91

IPCA2

41

8.30

19.49

10.96

33.82

55.93

34.26

IPCA3

39

5.11

4.17

4.26

15.15

18.23

10.58

IPCA4

37

1.98

2.21

2.00

12.90

12.67

10.39

IPCA5

35

1.20

1.52

1.32

7.73

8.78

8.44

Error

899

31.2

63.66

38.18

119.73

100.08

81.62

% treatment SS due to G

22.61

25.41

27.24

60.90

63.90

69.14

% treatment SS due to E

41.04

42.61

42.56

4.18

6.25

4.72

% treatment SS due to G^*E

36.35

31.98

30.19

34.91

29.84

26.14

% G^*E SS due to IPCA1

42.71

45.20

43.66

41.76

41.35

36.89

% G^*E SS due to IPCA2

25.17

35.31

29.53

22.93

31.07

26.94

% G^*E SS due to IPCA3

15.50

7.55

11.51

10.27

10.13

8.32

% G^*E SS due to IPCA4

6.00

3.84

5.40

8.75

7.04

8.17

% G^*E SS due to IPCA5

3.64

2.75

3.57

5.24

4.88

6.64